埃普斯坦-巴尔病毒对B细胞的生长转化需要IMPDH2诱导和核缩
Atsuko Sugimoto1,2,3, Takahiro Watanabe3, Kazuhiro Matsuoka2
1Department of Virology, Fujita Health University School of Medicine, Toyoake, Japan.
Microbiology spectrum
|July 6, 2023
概括
爱斯坦-巴尔病毒 (EBV) 诱导IMPDH2基因,导致核细胞扩大和B细胞生长转化. 在小鼠模型中,用mycophenolate mofetil (MMF) 抑制IMPDH2抑制了这种转化和PTLD.
科学领域:
- 病毒学和免疫学 病毒学和免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 埃普斯坦-巴尔病毒 (EBV) 感染启动B细胞生长转化,这是移植后淋巴增殖性疾病 (PTLD) 的关键步骤.
- 由IMPDH2基因诱导驱动的核细胞缩被认为有助于促进癌细胞生长.
研究的目的:
- 调查IMPDH2和核细胞大小在EBV介导的B细胞转化中的作用.
- 探索IMPDH2抑制对EBV驱动的PTLD的治疗潜力.
主要方法:
- 电子显微镜和EBV感染初级B细胞的免疫染色.
- RNA测序 (RNA-seq) 用于分析基因表达变化.
- 使用了EBNA2和LMP1淘汰EBV病毒.
- 通过使用基酸 (MPA) 评估IMPDH2抑制,并在小鼠异种移植模型中测试基酸 (MMF).
主要成果:
- EBV感染显著诱导IMPDH2表达,在第二天达到峰值,与增加的核细胞大小相关.
- 在初级EBV感染期间,EBNA2和MYC,但不是LMP1,被确定为IMPDH2的关键诱导剂.
- 通过MPA抑制IMPDH2,阻断了B细胞生长转化和细胞大小的减少;在小鼠中,MMF治疗改善了生存率和减少了脊髓巨变.
结论:
- EBV通过EBNA2和MYC诱导IMPDH2的表达,导致核细胞和细胞缩,这对B细胞增殖至关重要.
- IMPDH2诱导和核细胞扩大对于EBV驱动的B细胞转化至关重要.
- 菌酸莫菲提尔 (MMF) 显示出抑制EBV阳性PTLD的治疗潜力.
相关概念视频
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Cells of the Adaptive Immune Response
1.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
1.1K


